Selected Publications

Kim A. Reiss, MD; Sung Chul Hong, MS; Anup K. Kasi, MD; Eileen M. O’Reilly, MD; Shishir K Maithel, MD; Xin Yao, MD; Stanley R Hamilton, MD; Ben Boursi, MD; Michael J. Pishvaian, MD; Samuel J. Klempner, MD; Susan M. Domchek, MD; Paul Catalano, ScD; Elena G. Chiorean, MD; Philp A. Philip, MD; Peter J. O’Dwyer, MD: APOLLO: A Randomized Phase II Double-Blind Study of Olaparib versus Placebo Following Curative Intent Therapy in Patients with Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation: ECOG-ACRIN EA2192 ASCO Annual Meeting : 2023.

Caroline Salafia, Malwina Lewicka, Heather Symecko, Kelsey Spielman, Kelsey Breen, Rebecca Mueller, Amanda Catchings, Magan Trottier, Erin E. Salo-Mullen, Ibrahim Shah, Anna Arutyunova, Melissa Batson, Stacy Pundock, Elizabeth Schofield, Kenneth Offit, Zsofia K. Stadler, Maria I. Carlo, Vivek Narayan, Kim A. Reiss, Mark E. Robson, Susan M. Domchek, and Jada G. Hamilton, Ph.D: Impact of COVID-19 pandemic point-of-care genetic testing of advanced cancer patients IMPAHC : 2023.

Caroline Salafia, M.A; Malwina Lewicka, Ph.D; Heather Symecko, M.P.H; Kelsey Spielman, M.S., C.G.C., Kelsey Breen, M.S., M.Sc., C.G.C.; Rebecca Mueller, M.S., C.G.C.; Amanda Catchings, M.S., C.G.C.; Magan Trottier, M.Sc., M.Sc., C.G.C.; Erin E. Salo-Mullen, M.S., M.P.H., C.G.C.; Ibrahim Shah, B.A; Anna Arutyunova, B.S.; Melissa Batson, M.P.H.; Stacy Pundock, B.A.; Elizabeth Schofield, D.P.H.; Kenneth Offit, M.D., M.P.H.; Zsofia K. Stadler, M.D.; Maria I. Carlo, M.D.; Vivek Narayan M.D. ; Kim A. Reiss, M.D.; Mark E. Robson, M.D.; Susan M. Domchek, M.D.; Jada G. Hamilton, Ph.D., M.P.H.: Impact of ambiguity aversion on genetic testing concerns following “mainstreaming” hereditary cancer multigene panel testing IMPAHC : 2023.

Samuele Cannas et al: Liquid biopsy signature combining copy number instability and mutant KRAS detection is associated with survival for patients with metastatic pancreatic cancer AACR Annual Meeting : 2023.

Kim A. Reiss, MD; Sung Chul Hong, MS; Anup K. Kasi, MD; Eileen M. O’Reilly, MD; Shishir K Maithel, MD; Xin Yao, MD; Stanley R Hamilton, MD; Ben Boursi, MD; Michael J. Pishvaian, MD; Samuel J. Klempner, MD; Susan M. Domchek, MD; Paul Catalano, ScD; Elena G. Chiorean, MD; Philp A. Philip, MD; Peter J. O’Dwyer, MD: APOLLO: A Randomized Phase II Double-Blind Study of Olaparib versus Placebo Following Curative Intent Therapy in Patients with Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation: ECOG-ACRIN EA2192 ASCO GI, San Francisco, CA : 2023.

Timothy J Brown MD; Arielle Yablonovitch, PhD; Jennifer Yen, PhD; Lesli A. Kiedrowski, MS MPH; Erica Carpenter, PhD MBA; Katherine Nathanson, MD; Susan M. Domchek, MD and Kim A Reiss, MD: The identification of reversion mutations in patients with advanced pancreatic cancer and germline or somatic BRCA or PALB2 variants who were treated with maintenance rucaparib ASCO GI, San Francisco, CA : 2023.

Timothy Brown, MD; Kim A. Reiss, MD; Mark O'Hara, MD: Advancements in Systemic Therapy for Pancreas Cancer ASCO Educational Book : 2023.

Dylane Wineland, Anh N. Le, Ryan Hausler, Gregory Kelly, Emanuel Barrett, Heena Desai, Brad Wubbenhors3, John Pluta, Paul Bastian, Heather Symecko, Kurt D’Andrea, Abigail Doucette, Peter Gabriel, Kim A. Reiss, Anupma Nayak, Michael Feldman, Susan M. Domchek, Katherine L. Nathanson, Kara N. Maxwell: Biallelic BRCA loss and homologous recombination deficiency in non-breast/ovarian tumors in germline BRCA1/2 carriers JCO Precision Oncology : 2023.

Thatcher R. Heumann, Marina Baretti, Elizabeth A. Sugar, Jennifer N. Durham, Sheila Linden, Tamara Y. Lopez-Vidal, James Leatherman, Leslie Cope, Anup Sharma, Colin D. Weekes, Peter J. O’Dwyer, Kim A. Reiss, Dulabh K. Monga, Nita Ahuja & Nilofer S. Azad: A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence Clinic Epigenetics : 2022.

William Chapin and Kim A. Reiss: PARP Inhibitors and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma. Hematology/Oncology Clinics of North America 36 (5): 1019-1032,2022.

Academic Contact Information

Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-305
3400 Civic Center Blvd
Philadelphia, PA 19104
Phone: 215-360-0735
Patient appointments: 800-789-7366